Science Times Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.

Press releases published on August 10, 2026

Aug. 10, 2026

Le World Gold Council et Groupe Dynacor forment un partenariat stratégique pour promouvoir le traitement responsable de l’or et la formalisation de l’exploitation de minerai d’or artisanale et à petite échelle

Indeterminate GlobeNewswire

Aug. 10, 2026

CervoMed Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

Aug. 10, 2026

Terra Clean Energy Corp. Acquires and Digitizes Extensive Historic Database for the Marysvale Uranium Mines Project, Utah, United States

Indeterminate GlobeNewswire

Aug. 10, 2026

Eikon Therapeutics Appoints Johnny Bennett, Ph.D. to its Scientific Advisory Board

Indeterminate GlobeNewswire

Aug. 10, 2026

3D Systems Receives $9 Million Contract Award from U.S. Air Force for Advanced Large-Format Metal 3D Printing System

Indeterminate GlobeNewswire

Aug. 10, 2026

Discovery Announces Continued Exploration Success at Borden, Extends Main Zone Over Half a Kilometre

Indeterminate GlobeNewswire

Aug. 10, 2026

SAIC Appoints Financial Services Leader David Benson and Business Transformation Expert David Cush to Board of Directors

Indeterminate GlobeNewswire

Aug. 10, 2026

Kraig Biocraft Laboratories CEO Kim Thompson Publishes Thought Leadership Article on the Next Chapter of Authored Biology in Biocompare

Indeterminate GlobeNewswire

Aug. 10, 2026

Notice of Extraordinary General Meeting of Shareholders of Kaspi.kz

Indeterminate GlobeNewswire

Aug. 10, 2026

Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 10, 2026

Silicon Motion Technology Corporation Announces Proposed Offering of 0.00% Convertible Senior Notes due 2031

Indeterminate GlobeNewswire

Aug. 10, 2026

MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 10, 2026

Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates

Indeterminate GlobeNewswire

Aug. 10, 2026

Jade Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 10, 2026

Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film

Indeterminate GlobeNewswire

Aug. 10, 2026

Tonix Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Highlights

Indeterminate GlobeNewswire

Aug. 10, 2026

Shrinking Entry-Level Roles Put Leadership Pipeline at Risk

Indeterminate GlobeNewswire

Aug. 10, 2026

Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:

Indeterminate GlobeNewswire

Aug. 10, 2026

BrewDog Claims London's Summer Park Season with ‘Park IPA’

Indeterminate GlobeNewswire

Aug. 10, 2026

Sionna Therapeutics Reports Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update

Indeterminate GlobeNewswire